Allero Therapeutics BV

📍 Rotterdam, Netherlands🗓 Founded 2019👥 5 employees💰 Last funded Feb 2021
Biotechnology Research🌐 allerotherapeutics.com
Website LinkedIn
Allero Therapeutics is a Dutch biotech company that develops next generation immunotherapies for immune mediated disorders. Our goal is to develop novel targeted treatments that induce long-lasting antigen-specific tolerance. Our proprietary SOMIT (Specific Oromucosal Immunotherapy) technology combines a tolerance-inducing agent with novel oral patch mediated targeted delivery of specific antigens to the oral mucosa immune privilege.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
3
Investor activity2019–2021 · investors recorded per year
2019220211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Allero Therapeutics BV?
Allero Therapeutics BV has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did Allero Therapeutics BV last raise funding?
The most recent investment in Allero Therapeutics BV recorded on gritt.io was in February 2021.
When was Allero Therapeutics BV founded?
Allero Therapeutics BV was founded in 2019.
What industry is Allero Therapeutics BV in?
Allero Therapeutics BV operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Allero Therapeutics BV based?
Allero Therapeutics BV is headquartered in Rotterdam, Netherlands.